Skip to main content
HR 6228 98th Congress Private Legislation

An act providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.

Introduced: September 12, 1984 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 98th Congress ended
It never became law before the 98th Congress (1983–1984) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
  We don't have the full action history for this bill yet. Check back soon.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6228: An act providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.. 98th Congress. Open America. https://openamerica.io/bill/98-HR-6228/
MLA
"H.R. 6228: An act providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.." 98th Congress, 2026, Open America, https://openamerica.io/bill/98-HR-6228/.
Bluebook (legal)
H.R. 6228, 98th Cong. (2026), https://openamerica.io/bill/98-HR-6228/.
Markdown link
[H.R. 6228: An act providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.](https://openamerica.io/bill/98-HR-6228/)
Report a problem